Perforated Jejunal Adenocarcinoma in a COVID-19-Positive Patient^[*]

Abstract

Jejunal adenocarcinoma is a rare type of primary small bowel malignancy. It is generally diagnosed at late stages and as a surgical finding, with abdominal pain or discomfort being the main associated symptom. Cases presenting with perforation are even rarer, especially without disseminated disease. The relationship between cancer and coronavirus disease 2019 (COVID-19) is still being studied, as well as the postsurgical evolution of COVID-19 patients and its possible causality of intestinal perforation. We present the case of a perforated jejunal adenocarcinoma in a COVID-19-positive patient, in whom the symptomatology secondary to the perforation led to an early diagnosis, treatment and adequate postsurgical evolution, despite the concomitant condition.

Resumo

O adenocarcinoma jejunal é um tipo raro de malignidade primária do intestino delgado, o qual geralmente é diagnosticado em estágios tardios e como achado cirúrgico, sendo a dor ou o desconforto abdominal o principal sintoma associado. Casos que apresentam perfuração são ainda mais raros, principalmente sem doença disseminada. A relação entre câncer e a cornonavirus disease 2019 (covid-19) ainda está sendo estudada, assim como a evolução pós-cirúrgica de pacientes com covid-19 e sua possível causalidade de perfuração intestinal. Apresentamos o caso de um adenocarcinoma jejunal perfurado em um paciente positivo para covid-19, em que a sintomatologia secundária à perfuração levou a um diagnóstico precoce, tratamento e evolução pós-cirúrgica adequada, apesar da condição concomitante.

Keywords

adenocarcinoma - COVID-19 - intestinal perforation - jejunal neoplasms

Palavras-chave

adenocarcinoma - covid-19 - neoplasias jejunais - perfuração intestinal

^* Study conducted at Hospital General de Zona 1A, Department of Surgery, Instituto Mexicano del Seguro Social, Ciudad de México, México.

Publication History

Received: 16 July 2020

Accepted: 02 September 2020

Article published online:
24 May 2021

• References

• 1 Li J, Wang Z, Liu N, Hao J, Xu X. Small bowel adenocarcinoma of the jejunum: a case report and literature review. World J Surg Oncol 2016; 14 (01) 177-182 DOI: 10.1186/s12957-016-0932-3.
• 2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70 (01) 7-30 DOI: 10.3322/caac.21590.
• 3 Rongviriyapanich A. Adenocarcinoma of jejunum. J Surg Case Rep 2018; 2018 (08) rjy234 DOI: 10.1093/jscr/rjy234.
• 4 World Health Organization. 2020 WHO Coronavirus Disease (COVID-19) Dashboard. [online] Covid19.who.int. Available at: <https://covid19.who.int/> [Accessed 14 July 2020]
• 5 Gupta A, Madhavan MV, Sehgal K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26 (07) 1017-1032 DOI: 10.1038/s41591-020-0968-3.
• 6 Xie X, Zhou Z, Song Y, Dang C, Zhang H. Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum. Sci Rep 2017; 7 (01) 15163 DOI: 10.1038/s41598-017-15633-w.
• 7 McLaughlin PD, Maher MM. Primary malignant diseases of the small intestine. AJR Am J Roentgenol 2013; 201 (01) W9-14 DOI: 10.2214/AJR.12.8492.
• 8 Reynolds I, Healy P, Mcnamara DA. Malignant tumours of the small intestine. Surgeon 2014; 12 (05) 263-270 DOI: 10.1016/j.surge.2014.02.003.
• 9 Negoi I, Paun S, Hostiuc S. et al. Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo) 2015; 13 (04) 500-505 DOI: 10.1590/s1679-45082015ao3380.
• 10 Cimpeanu E, Zafar W, Circiumaru I, Prozumenshikov A, Salman S. Rare presentation of small bowel adenocarcinoma with neuroendocrine differentiation in the jejunum: A case report and summary of diagnostic and management options. Mol Clin Oncol 2019; 11 (05) 461-464 DOI: 10.3892/mco.2019.1925.
• 11 Barsouk A, Rawla P, Barsouk A, Thandra KC. Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention. Med Sci (Basel) 2019; 7 (03) 46 DOI: 10.3390/medsci7030046.
• 12 Young JI, Mongoue-Tchokote S, Wieghard N. et al. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer. Dis Colon Rectum 2016; 59 (04) 306-315 DOI: 10.1097/dcr.0000000000000562.
• 13 Ahmed N, Rana HN. Primary Jejunal adenocarcinoma - An unsuspected culprit. J Pak Med Assoc 2018; 68 (03) 471-474
• 14 Puccini A, Battaglin F, Lenz HJ. Management of Advanced Small Bowel Cancer. Curr Treat Options Oncol 2018; 19 (12) 69 DOI: 10.1007/s11864-018-0592-3.
• 15 Coit DG, Kelsen D, Tang LH. et al. AJCC Cancer Staging Manual. 8th ed.. Chicago: Amin MB; 2017: 221
• 16 SEER. 2020 Cancer Of The Small Intestine - Cancer Stat Facts. [online] Available at: <https://seer.cancer.gov/statfacts/html/smint.html> [Accessed 16 July 2020]
• 17 Overman MJ, Hu CY, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol 2012; 19 (05) 1439-1445 DOI: 10.1245/s10434-011-2173-6.
• 18 Tang L, Cheng X, Tian C. et al. Computed tomography (CT) intestinal alterations of Coronavirus Disease 2019 (COVID-19) from the imaging perspective: a case description. Quant Imaging Med Surg 2020; 10 (05) 1145-1149 DOI: 10.21037/ qims.2020.04.09.
• 19 Schmulson M, Dávalos MF, Berumen J. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19. Rev Gastroenterol Mex 2020; 85 (03) 282-287 DOI: 10.1016/j.rgmx.2020.04.001.
• 20 Doglietto F, Vezzoli M, Gheza F. et al. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Surg 2020; ••• DOI: 10.1001/jamasurg.2020.2713.